MTOR and breast cancer: The dual PI3K/MTOR inhibitor NVP-BEZ235 acts as a robust anticancer compound, particularly for breast cancer.33, 34, 35, 36, 37 Here, BEZ235 alone was cytotoxic in 4T1 cells in a dose-dependent manner (Figure 1c).